Urgent Updates | January 26, 2022

CDC UPDATES CONSUMER MASK WEBSITE TO EMPHASIZE PROTECTION, FIT, AND COMFORT

Masking is a critical public health tool to prevent the spread of COVID-19, and it is important to remember that any mask is better than no mask.

CDC continues to recommend wearing the most protective mask that fits well and will wear consistently. Clarified that people can choose respirators such as N95s and KN95s, including removing concerns related to supply shortages for N95s.
Full Access: CDC

TOO SOON TO TREAT COVID-19 LIKE FLU AS OMICRON SPREADS: WHO

Evidence, is emerging that Omicron is affecting the upper respiratory tract more than the lungs, causing milder symptoms than previous variants. But the WHO has cautioned more studies are still needed to prove this and that it should not yet be seen as a flu-like endemic illness.
Full Access: MedEdge

EPSTEIN-BARR VIRUS (EBV) A LIKELY LEADING CAUSE OF MULTIPLE SCLEROSIS

EBV is the likely cause of Multiple Sclerosis (MS), new research confirms. Investigators found the risk of MS increased 32-fold following EBV infection. Researchers examined 801 MS case patients and 1566 matched controls without MS. Only one of the 801 MS case patients had no serologic evidence of EBV.
Full Access: Medscape

PROSPECTIVE OBSERVATIONAL STUDY OF CLINICAL OUTCOMES AFTER INTRAVENOUS MAGNESIUM FOR MODERATE AND SEVERE ACUTE ASTHMA EXACERBATIONS IN CHILDREN

There is limited knowledge regarding whether intravenous magnesium (IV-Mg) improves outcomes in children with acute asthma exacerbations. This is a secondary analysis using data from a prospective observational cohort of children aged 5 to 17 years with moderate and severe exacerbations. Researchers found that among children with moderate and severe exacerbations, IV-Mg is associated with increased exacerbation severity, increased risk for hospitalization, and no acceleration in exacerbation resolution among hospitalized participants.
Full Access: Journal of Allergy and Immunology